Morgan Adam

Morgan Adam is listed in filings as Director at Heron Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 3, 2026, including purchase activity. Recent filings connect the profile to Heron Therapeutics, Inc. (HRTX) and Alimera Sciences, Inc. (ALIM). The current snapshot covers public activity from Sep 16, 2024 to Feb 3, 2026. Reported amounts are shown as $2.6M to $61.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.